Effects of Living High-Training Low and High on Body Composition and Metabolic Risk Markers in Overweight and Obese Females

Table 4

Changes in the serum lipid profile after 4 weeks of the intervention.

Variable	Pre	Post	value (interaction effect)	η^2 (effect size)
FFA, mmol/L
NG	0.46 ± 0.11	0.79 ± 0.30^$	0.206	0.098
HG	0.55 ± 0.20	1.05 ± 0.26^$
TGs, mmol/L
NG	1.05 ± 0.33	0.85 ± 0.18	0.554	0.021
HG	0.97 ± 0.30	0.85 ± 0.13
TC, mmol/L
NG	4.49 ± 0.79	3.87 ± 0.43^$	0.040	0.225
HG	4.37 ± 1.16	4.32 ± 0.99
LDL-C, mmol/L
NG	2.50 ± 0.75	2.34 ± 0.34	0.545	0.022
HG	2.50 ± 0.93	2.52 ± 0.75
HDL-C, mmol/L
NG	1.29 ± 0.22	1.11 ± 0.19^&	0.055	0.200
HG	1.27 ± 0.20	1.30 ± 0.33
LDL-C/HDL-C
NG	1.96 ± 0.53	2.16 ± 0.50	0.305	0.062
HG	2.04 ± 0.98	2.04 ± 0.82
APO-A1, g/L
NG	1.16 ± 0.16	1.00 ± 0.13^$	0.042	0.221
HG	1.23 ± 0.14	1.17 ± 0.23
APO-B, g/L
NG	0.72 ± 0.16	0.67 ± 0.10	0.203	0.094
HG	0.70 ± 0.26	0.71 ± 0.19
APO-A1/APO-B
NG	1.69 ± 0.42	1.54 ± 0.38^$	0.566	0.020
HG	1.90 ± 0.50	1.71 ± 0.43^$

Pre, preintervention. Post, postintervention. ^$; ^&, pre versus post. NG: normoxic group; HG: hypoxic group; FFA: free fatty acid; TC: total cholesterol; TGs: total triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; APO-A1 and APO-B: apolipoprotein A1 and apolipoprotein B.